Intravenous Immunoglobulin-Induced Hemolytic Anemia After Thoracoscopic Thymectomy for Myasthenia Gravis
- 1 June 2014
- journal article
- case report
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 97 (6), 2175-2177
- https://doi.org/10.1016/j.athoracsur.2013.08.024
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravisThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders [RETIRED]Neurology, 2012
- Ten-Year Results of Thoracoscopic Unilateral Extended Thymectomy Performed in Nonthymomatous Myasthenia GravisAnnals of Surgery, 2011
- Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology, 2010
- Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized PatientsClinical Journal of the American Society of Nephrology, 2009
- Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysisTransfusion, 2008
- Complications of therapeutic plasma exchange: A prospective study of 1,727 proceduresJournal of Clinical Apheresis, 2007
- Outcomes After 151 Extended Transcervical Thymectomies for Myasthenia GravisThe Annals of Thoracic Surgery, 2006
- Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravisThe Journal of Thoracic and Cardiovascular Surgery, 2004